153 related articles for article (PubMed ID: 22864660)
41. Frequent mismatch-repair defects link prostate cancer to Lynch syndrome.
Dominguez-Valentin M; Joost P; Therkildsen C; Jonsson M; Rambech E; Nilbert M
BMC Urol; 2016 Mar; 16():15. PubMed ID: 27013479
[TBL] [Abstract][Full Text] [Related]
42. Evidence for breast cancer as an integral part of Lynch syndrome.
Buerki N; Gautier L; Kovac M; Marra G; Buser M; Mueller H; Heinimann K
Genes Chromosomes Cancer; 2012 Jan; 51(1):83-91. PubMed ID: 22034109
[TBL] [Abstract][Full Text] [Related]
43. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
[TBL] [Abstract][Full Text] [Related]
44. Contribution of ultrasonography to endometrial cancer screening in patients with hereditary nonpolyposis colorectal cancer/Lynch syndrome.
Lécuru F; Huchon C; Metzger U; Bats AS; Le Frère Belda MA; Olschwang S; Puig PL
Int J Gynecol Cancer; 2010 May; 20(4):583-7. PubMed ID: 20686377
[TBL] [Abstract][Full Text] [Related]
45. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.
van der Post RS; Kiemeney LA; Ligtenberg MJ; Witjes JA; Hulsbergen-van de Kaa CA; Bodmer D; Schaap L; Kets CM; van Krieken JH; Hoogerbrugge N
J Med Genet; 2010 Jul; 47(7):464-70. PubMed ID: 20591884
[TBL] [Abstract][Full Text] [Related]
46. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
47. Segregation of a novel MLH1 mutation in an Iranian Lynch syndrome family.
Ghafouri-Fard S; Fardaei M; Lankarani KB; Miryounesi M
Gene; 2015 Oct; 570(2):304-5. PubMed ID: 26149658
[TBL] [Abstract][Full Text] [Related]
48. Risk of cancer in cases of suspected lynch syndrome without germline mutation.
Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R
Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017
[TBL] [Abstract][Full Text] [Related]
49. Cancer risks for MLH1 and MSH2 mutation carriers.
Dowty JG; Win AK; Buchanan DD; Lindor NM; Macrae FA; Clendenning M; Antill YC; Thibodeau SN; Casey G; Gallinger S; Marchand LL; Newcomb PA; Haile RW; Young GP; James PA; Giles GG; Gunawardena SR; Leggett BA; Gattas M; Boussioutas A; Ahnen DJ; Baron JA; Parry S; Goldblatt J; Young JP; Hopper JL; Jenkins MA
Hum Mutat; 2013 Mar; 34(3):490-7. PubMed ID: 23255516
[TBL] [Abstract][Full Text] [Related]
50. Malignant fibrous histiocytoma is a rare Lynch syndrome-associated tumor in two German families.
Brieger A; Engels K; Schaefer D; Plotz G; Zeuzem S; Raedle J; Trojan J
Fam Cancer; 2011 Sep; 10(3):591-5. PubMed ID: 21598002
[TBL] [Abstract][Full Text] [Related]
51. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
[TBL] [Abstract][Full Text] [Related]
52. Clinical and molecular characterization of colorectal cancer in young Moroccan patients.
Benmoussa A; Badre W; Pedroni M; Zamiati S; Badre L; Digregorio C; De Leon MP; Nadifi S
Turk J Gastroenterol; 2012; 23(6):686-90. PubMed ID: 23794306
[TBL] [Abstract][Full Text] [Related]
53. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.
Obermair A; Youlden DR; Young JP; Lindor NM; Baron JA; Newcomb P; Parry S; Hopper JL; Haile R; Jenkins MA
Int J Cancer; 2010 Dec; 127(11):2678-84. PubMed ID: 20533284
[TBL] [Abstract][Full Text] [Related]
54. Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.
Zighelboim I; Powell MA; Babb SA; Whelan AJ; Schmidt AP; Clendenning M; Senter L; Thibodeau SN; de la Chapelle A; Goodfellow PJ
Fam Cancer; 2009; 8(4):501-4. PubMed ID: 19672700
[TBL] [Abstract][Full Text] [Related]
55. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
[TBL] [Abstract][Full Text] [Related]
56. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
57. A novel germline MLH1 mutation causing Lynch Syndrome in patients from the Republic of Macedonia.
Hiljadnikova-Bajro M; Josifovski T; Panovski M; Dimovski AJ
Croat Med J; 2012 Oct; 53(5):496-501. PubMed ID: 23100212
[TBL] [Abstract][Full Text] [Related]
58. Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.
Thodi G; Fostira F; Sandaltzopoulos R; Nasioulas G; Grivas A; Boukovinas I; Mylonaki M; Panopoulos C; Magic MB; Fountzilas G; Yannoukakos D
BMC Cancer; 2010 Oct; 10():544. PubMed ID: 20937110
[TBL] [Abstract][Full Text] [Related]
59. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
[TBL] [Abstract][Full Text] [Related]
60. Two new MLH1 germline mutations in Brazilian Lynch syndrome families.
Dominguez MV; Bastos EP; Santos EM; Oliveira LP; Ferreira FO; Carraro DM; Rossi BM
Int J Colorectal Dis; 2008 Dec; 23(12):1263-4. PubMed ID: 18594839
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
